bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 16, 2023
Abstract
Viral
glycoproteins
mediate
entry
into
host
cells,
thereby
dictating
range
and
pathogenesis.
In
addition,
they
constitute
the
principal
target
of
neutralizing
antibody
responses,
making
them
important
antigens
in
vaccine
development.
Recombinant
vesicular
stomatitis
virus
(VSV)
encoding
foreign
can
provide
a
convenient
safe
surrogate
system
to
interrogate
function,
evolution,
antigenicity
viral
from
viruses
that
are
difficult
manipulate
or
those
requiring
high
biosafety
levels
containment.
However,
production
recombinant
VSV
be
technically
challenging.
this
work,
we
present
an
efficient
robust
plasmid-based
for
glycoproteins.
We
validate
using
different
families,
including
arenaviruses,
coronaviruses,
hantaviruses,
as
well
highlight
their
utility
studying
effects
mutations
on
fitness.
Overall,
methods
described
herein
facilitate
study
both
native
serve
basis
VSV-based
vaccines.
MedComm,
Journal Year:
2022,
Volume and Issue:
3(3)
Published: Aug. 16, 2022
Abstract
Since
the
start
of
coronavirus
disease
2019
(COVID‐19)
pandemic,
new
variants
severe
acute
respiratory
syndrome
2
(SARS‑CoV‑2)
have
emerged,
accelerating
spread
virus.
Omicron
was
defined
by
World
Health
Organization
in
November
2021
as
fifth
“variant
concern”
after
Alpha,
Beta,
Gamma,
and
Delta.
In
recent
months,
has
become
main
epidemic
strain.
Studies
shown
that
carries
more
mutations
than
Delta,
wild‐type,
facilitating
immune
escape
its
transmission.
This
review
focuses
on
variant's
origin,
transmission,
biological
features,
subvariants,
mutations,
escape,
vaccination,
detection
methods.
We
also
discuss
appropriate
preventive
therapeutic
measures
should
be
taken
to
address
challenges
posed
variant.
is
valuable
guide
surveillance,
prevention,
development
vaccines
other
therapies
for
variants.
It
desirable
develop
a
efficient
vaccine
against
variant
take
effective
constrain
promote
public
health.
Biomaterials Research,
Journal Year:
2023,
Volume and Issue:
27(1)
Published: Feb. 9, 2023
Natural
products
can
serve
as
one
of
the
alternatives,
exhibiting
high
potential
for
treatment
and
prevention
COVID-19,
caused
by
SARS-CoV-2.
Herein,
we
report
a
screening
platform
to
test
antiviral
efficacy
natural
product
library
against
SARS-CoV-2
verify
their
activity
using
lung
organoids.
Since
is
classified
risk
group
3
pathogen,
drug
assay
must
be
performed
in
biosafety
level
(BSL-3)
laboratory.
To
circumvent
this
limitation,
pseudotyped
viruses
(PVs)
have
been
developed
replacements
live
We
PVs
containing
spikes
from
Delta
Omicron
variants
improved
infection
an
angiotensin-converting
enzyme
2
(ACE2)-dependent
manner.
Human
induced
pluripotent
stem
cells
(hiPSCs)
derived
organoids
were
generated
therapeutic
products.
Flavonoids
our
had
strong
Delta-
or
Omicron-spike-containing
without
affecting
cell
viability.
aimed
develop
strategies
discover
dual
function
either
inhibiting
at
beginning
cycle
reducing
spike
stability
following
infection.
When
are
already
infected
with
virus,
active
flavonoids
degradation
protein
exerted
anti-inflammatory
effects.
Further
experiments
confirmed
that
organoid
models.
This
will
open
new
paths
providing
promising
standard
system
discovering
novel
leads
help
candidates
clinical
investigation
therapeutics
COVID-19.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 10, 2024
Abstract
The
worldwide
spread
of
SARS-CoV-2
has
been
characterised
by
the
emergence
several
variants
concern
(VOCs)
presenting
an
increasing
number
mutations
in
viral
genome.
spike
glycoprotein,
responsible
for
engaging
receptor
ACE2,
exhibits
highest
density
mutations,
suggesting
ongoing
evolution
to
optimize
entry.
However,
previous
studies
focussed
on
isolated
molecular
interactions,
neglecting
intricate
composition
plasma
membrane
and
interplay
between
attachment
factors.
Our
study
explores
role
avidity
complexity
modulating
virus-host
binding
kinetics
during
early
stages
entry
original
Wuhan
strain
three
VOCs:
Omicron
BA.1,
Delta,
Alpha.
We
employ
fluorescent
liposomes
decorated
with
from
VOCs
as
virion
mimics
single-particle
tracking
native
supported
lipid
bilayers
derived
pulmonary
Calu-3
cells.
findings
reveal
increase
affinity
multivalent
bond
cell
surface
driven
increased
association
rate.
show
that
heparan
sulfate
(HS),
a
sulfated
glycosaminoglycan
commonly
expressed
cells’
membrane,
plays
central
interaction
we
observe
shift
its
screening
ACE2
important
factor
Omicron.
This
is
caused
∼10-fold
Omicron’s
HS
compared
strain,
shown
using
atomic
force
microscopy-based
single-molecule
spectroscopy.
results
importance
coreceptors,
particularly
HS,
modulation
VOCs.
highlight
transition
variants’
strategy
towards
use
initial
docking
site,
which
likely
shaping
tropism
infection
upper
airways,
milder
symptoms,
higher
transmissibility.
Viruses,
Journal Year:
2022,
Volume and Issue:
14(6), P. 1332 - 1332
Published: June 18, 2022
The
global
spread
of
SARS-CoV-2
and
its
variants
poses
a
serious
threat
to
human
health
worldwide.
Recently,
the
emergence
Omicron
has
presented
new
challenge
prevention
control
COVID-19
pandemic.
A
convenient
reliable
in
vitro
neutralization
assay
is
an
important
method
for
validating
efficiency
antibodies,
vaccines,
other
potential
drugs.
Here,
we
established
effective
based
on
pseudovirus
carrying
full-length
spike
(S)
protein
HIV-1
backbone,
with
luciferase
reporter
gene
inserted
into
non-replicate
genome.
key
parameters
packaging
were
optimized,
including
ratio
S
expression
plasmids
HIV
backbone
collection
time
Alpha,
Beta,
Gamma,
Kappa,
particles.
was
validated
using
several
approved
or
developed
monoclonal
underscoring
that
can
escape
some
neutralizing
such
as
REGN10987
REGN10933,
while
S309
ADG-2
still
function
reduced
capability.
capacity
convalescent
plasma
from
patients
Wuhan
tested
against
these
pseudoviruses,
revealing
immune
evasion
Omicron.
Our
work
practical
pseudovirus-based
variants,
which
be
conducted
safely
under
biosafety
level-2
(BSL-2)
conditions,
this
will
promising
tool
studying
characterizing
vaccines
therapeutic
candidates
Omicron-included
variants.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 9, 2023
Abstract
Detecting
neutralizing
antibodies
(NAbs)
to
SARS-CoV-2
variants
is
crucial
for
controlling
COVID-19
spread.
We
developed
a
high-throughput
assay
the
broad
systematic
examination
of
NAbs
eleven
variants,
which
include
D614G,
Alpha,
Beta,
Gamma,
Delta,
Kappa,
and
Omicron
sub-lineages
BA.1-BA.5.
The
cost-effective,
reliable,
35-fold
more
sensitive
than
Luminex
technology,
can
new
during
evolution.
Importantly,
our
results
highly
correlated
with
commercial
IgG
serological
(R
=
0.89),
FDA-approved
cPass
sVNT
0.93),
pseudivirus-based
0.96,
R
0.66,
0.65)
live
virus
based
neutralization
0.79,
0.64)
.
Using
this
platform,
we
constructed
comprehensive
overview
interactions
between
variants’
Spike
trimer
proteins
ACE2
receptors,
identified
polyclonal
Ab
activity.
Furthermore,
when
compared
D614G
variant,
found
that
serum
elicited
by
third
dose
vaccine
demonstrated
decreased
inhibition
multiple
including
Gamma
(0.94×),
Alpha
(0.91×),
Delta
Beta
(0.81×),
Kappa
BA.2
(0.44×),
BA.1
(0.43×),
BA.3
(0.41×),
BA.5
(0.35×)
BA.4
(0.33×),
in
cohort
56
vaccinated
individuals.
Altogether,
proteomics
platform
proves
be
an
effective
tool
detect
population
aid
development
future
vaccines
vaccination
strategies.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(3), P. 338 - 338
Published: Feb. 22, 2024
The
continuous
emergence
of
SARS-CoV-2
variants
caused
the
persistence
COVID-19
epidemic
and
challenged
effectiveness
existing
vaccines.
viral
proteases
are
most
attractive
targets
for
developing
antiviral
drugs.
In
this
scenario,
our
study
explores
use
HIV-1
protease
inhibitors
against
SARS-CoV-2.
An
in
silico
screening
a
library
identified
four
anti-HIV
compounds
able
to
interact
with
3CLpro
Thus,
vitro
studies
were
designed
evaluate
their
potential
We
employed
pseudovirus
technology
simulate,
highly
safe
manner,
adsorption
alpha
(α-SARS-CoV-2)
omicron
(ο-SARS-CoV-2)
inhibitory
mechanism
selected
cell–virus
interaction.
results
reported
mild
activity
PLpro,
but
efficient
effects
on
internalization
both
mediated
by
cathepsin
B/L.
Our
findings
provide
insights
into
feasibility
using
drugs
exhibiting
other
viruses
host
required
entry.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: June 25, 2024
Abstract
Viral
glycoproteins
mediate
entry
into
host
cells,
thereby
dictating
range
and
pathogenesis.
In
addition,
they
constitute
the
principal
target
of
neutralizing
antibody
responses,
making
them
important
antigens
in
vaccine
development.
Recombinant
vesicular
stomatitis
virus
(VSV)
encoding
foreign
can
provide
a
convenient
safe
surrogate
system
to
interrogate
function,
evolution,
antigenicity
viral
from
viruses
that
are
difficult
manipulate
or
those
requiring
high
biosafety
level
containment.
However,
production
recombinant
VSV
be
technically
challenging.
this
work,
we
present
an
efficient
robust
plasmid-based
for
glycoproteins.
We
validate
using
different
families,
including
arenaviruses,
coronaviruses,
hantaviruses,
as
well
highlight
their
utility
studying
effects
mutations
on
fitness.
Overall,
methods
described
herein
facilitate
study
both
native
serve
basis
VSV-based
vaccines.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 11094 - 11094
Published: Oct. 15, 2024
Engineered
viral
vectors
designed
to
deliver
genetic
material
specific
targets
offer
significant
potential
for
disease
treatment,
safer
vaccine
development,
and
the
creation
of
novel
biochemical
research
tools.
Viral
tropism,
specificity
a
virus
infecting
particular
host,
is
often
modified
in
recombinant
viruses
achieve
precise
delivery,
minimize
off-target
effects,
enhance
transduction
efficiency,
improve
safety.
Key
factors
influencing
tropism
include
surface
protein
interactions
between
host-cell,
availability
host-cell
machinery
replication,
host
immune
response.
This
review
explores
current
strategies
modifying
by
altering
their
proteins.
We
provide
an
overview
recent
advancements
targeting
non-enveloped
(adenovirus
adeno-associated
virus)
enveloped
(retro/lentivirus,
Rabies,
Vesicular
Stomatitis
Virus,
Herpesvirus)
cell
types.
Additionally,
we
discuss
approaches,
such
as
rational
design,
directed
evolution,
silico
machine
learning-based
methods,
generating
AAV
variants
with
desired
use
chimeric
envelope
proteins
pseudotyping
viruses.
Finally,
highlight
applications
these
challenges
future
directions
engineering
tropism.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(3), P. 1080 - 1080
Published: Jan. 21, 2023
Theacrine
and
strictinin
of
Yunnan
Kucha
tea
prepared
from
a
mutant
variety
wild
Pu’er
plants
were
two
major
ingredients
responsible
for
the
anti-influenza
activity.
As
COVID-19
outbreak
is
still
lurking,
developing
safe
cost-effective
therapeutics
an
urgent
need.
This
study
aimed
to
evaluate
effects
these
compounds
on
infection
mouse
hepatitis
virus
(MHV),
β-coronavirus
serving
as
surrogate
SARS-CoV.
Treatment
with
(100
μM),
but
not
theacrine,
completely
eliminated
MHV
infection,
indicated
by
pronounced
reduction
in
plaque
formation,
nucleocapsid
protein
expression,
progeny
production
MHV.
Subsequently,
time-of-drug
addition
protocol,
including
pre-,
co-,
or
post-treatment,
was
exploited
further
possible
mechanism
antiviral
activity
mediated
strictinin,
remdesivir,
potential
drug
treatment
SARS-CoV-2,
used
positive
control
against
infection.
The
results
showed
that
all
three
treatments
remdesivir
(20
μM)
blocked
In
contrast,
no
significant
effect
observed
when
cells
pre-treated
prior
while
inhibition
introduced
upon
viral
adsorption
(co-treatment)
after
entry
(post-treatment).
Of
note,
compared
co-treatment
group,
inhibitory
more
striking
post-treatment
group.
These
indicate
suppresses
multiple
mechanisms;
it
possibly
interferes
also
critical
step(s)
Evidently,
significantly
inhibited
might
be
suitable
ingredient
protection
coronavirus